2 Growth Stocks to Hold for the Next Decade (Hint: These Aren’t AI Stocks)

The article highlights two non-AI healthcare growth stocks worth holding for the next decade: Axsome Therapeutics, a biotech company with promising pipeline expansion including Auvelity's label expansion into Alzheimer's treatment, and Eli Lilly, which dominates the weight loss and diabetes markets with strong revenue and earnings growth. Both companies are positioned to deliver solid long-term returns through patent protection and diversified product pipelines.